Overview

Varenicline In-Patient Study

Status:
Completed

Trial end date:
2014-10-01

Target enrollment:

Participant gender:

Summary

This Investigator Initiated Research Award (IIR Award #WS981308) is a two-part pilot study that aims to examine acceptability and feasibility of varenicline use during an acute (72-hr) smoke-free hospitalization (Part 1) and 4-weeks post-hospitalization (Part 2).

Phase:

Phase 2

Details

Lead Sponsor:

Stanford University

Collaborator:

Pfizer

Treatments:

Varenicline